Enquire Now

Business Model

CMPV Consultancy LLP (also presented as ClovisMed Pharmacovigilance Consultancy) is an India-based professional services firm specializing in pharmacovigilance — the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. 

Founded in March 2024 and registered as an LLP with the Registrar of Companies in Cuttack, Odisha, India, the firm operates with a focus on supporting pharmaceutical companies, biotech organizations, healthcare institutions, and related stakeholders in ensuring drug safety and regulatory compliance. 

🧩 1. Value Proposition

CMPV Consultancy’s core business proposition centers on delivering expert pharmacovigilance services that help clients:

  • Maintain patient safety by ensuring effective monitoring and reporting of adverse drug events. 
  • Ensure regulatory compliance with both local (e.g., CDSCO-India) and global health authority standards. 
  • Improve internal safety systems through audits, risk mitigation strategies, and documentation support. 
  • Build organizational capability via training, intelligence, and qualified personnel support. 

The company emphasizes expertise, customized solutions, confidentiality, and client-centric service delivery as core differentiators. 

🛠️ 2. Key Services (Revenue Streams)

CMPV generates revenue by offering a suite of specialized service offerings in pharmacovigilance, including:

🔹 Pharmacovigilance Operational Services

  • Individual Case Safety Report (ICSR) management
  • Adverse Event Reporting & processing
  • Signal detection and risk management
    These services help clients manage and report safety data accurately and timely. 

🔹 Consulting & Compliance Services

  • Regulatory compliance support
  • Regulatory intelligence & strategy
  • Benefit-risk assessments
    These ensure alignment with evolving regulatory frameworks and minimize risk of non-compliance. 

🔹 Quality Assurance & Audit Services

  • Internal pharmacovigilance audits
  • Risk-based audits
  • Remote audit support
  • Corrective & Preventive Action (CAPA) guidance
    CMPV assesses and strengthens clients’ internal pharmacovigilance system quality. 

🔹 Training & Education

  • Pharmacovigilance training programs tailored for client teams
    This builds internal capability in drug safety and compliance. 

🔹 Local QPPV (Qualified Person for Pharmacovigilance) Support

  • Provision of QPPV expertise
  • 24/7 compliance stewardship
  • Reporting & documentation services
    This is particularly suited for companies requiring in-region regulatory oversight. 

👥 3. Customer Segments

CMPV serves a range of clients, including:

  • Pharmaceutical companies (large, mid-size, and emerging startups)
  • Biotech & medical product manufacturers
  • Healthcare organizations and hospitals
  • Contract Research Organizations (CROs)
  • Academic institutions needing pharmacovigilance support or training 

🔑 4. Channels

CMPV engages clients and delivers services through:

  • Direct consulting engagements
  • Collaborative partnerships and MOUs (e.g., with PV.app for AI-driven data management tools) 
  • Online presence via official site and digital outreach
  • Professional networks in the pharmaceutical and regulatory domain
  • Training workshops and customized engagements

🤝 5. Strategic Partnerships & Innovation

  • International collaboration with PV.app — an AI-powered platform to improve data entry and reporting workflows, which enhances the firm’s technology offering. 

This partnership expands CMPV’s service delivery model into technology-enabled pharmacovigilance solutions — enabling faster, compliant data submissions and improved quality control.

🧠 6. Key Resources

To operate its consultancy business, CMPV leverages:

  • Expert pharmacovigilance professionals and regulatory specialists
  • Training content and frameworks for internal and client learning
  • Intellectual property in audit methods, reporting processes, and compliance methodologies
  • Technology partnerships (e.g., PV.app platform) 

🏭 7. Cost Structure

Major ongoing costs likely include:

  • Salaries and professional consultant fees
  • Regulatory and compliance research tools
  • Audit and reporting infrastructure
  • Marketing and business development expenses
  • Training development and delivery costs
  • Technology platform integration and support

📊 8. Competitive Advantage

CMPV distinguishes itself through:

  • Niche specialization in pharmacovigilance — not general consulting.
  • Deep regulatory expertise tailored for drug safety and global compliance.
  • Comprehensive service offerings from operational to strategic consulting.
  • Technology integration (AI-assisted reporting) through partnerships. 

🎯 9. Vision & Long-Term Goals

CMPV aims to:

  • Become a global benchmark in pharmacovigilance consulting
  • Expand its services across 50+ countries by 2030
  • Enhance drug safety culture and systemic compliance in the healthcare sector
    Their mission emphasizes patient safety and professional development in the field.